# US Needle-Free Injection Market

> US Needle-Free Injection Market Research Report: Size, Share, Trend Analysis By Applications (Vaccination, Insulin Delivery, Pain Management, Hormonal Therapy), By Technology (Jet Injector, Nanoparticle Based Delivery, Laser Powered Injection), By End Use (Hospitals, Home Care, Pharmaceutical Companies) and By Dosage Form (Solid, Liquid, Lyophilized) - Growth Outlook & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 8.58%
- **2024:** $ 1,330.11 Million
- **2025:** $ 1,444.23 Million
- **2035:** $ 3,289.61 Million
- **Key Players:** Zynerba Pharmaceuticals (US), MedImmune (GB), PharmaJet (US), Injex Pharma (DE), Valeritas Holdings (US), Vaxart (US), West Pharmaceutical Services (US), Antares Pharma (US)

**Report ID:** MRFR/HC/51545-HCR · **Pages:** 200 · **Author:** Rahul Gotadki · **Last Updated:** February 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/us-needle-free-injection-market-53306

---

## Market Summary

## **US Needle-Free Injection Market Overview**

As per MRFR analysis, the US Needle-Free Injection Market Size was estimated at 1.23 (USD Billion) in 2023.

The US Needle-Free Injection Market Industry is expected to grow from 1.33(USD Billion) in 2024 to 3.29 (USD Billion) by 2035. The US Needle-Free Injection Market CAGR (growth rate) is expected to be around 8.585% during the forecast period (2025 - 2035).

### **Key US Needle-Free Injection Market Trends Highlighted**

The US Needle-Free Injection Market is experiencing significant growth influenced by several key market drivers. One major driver is the increasing demand for pain-free and safe drug delivery systems, which aligns with patient preferences for less invasive procedures. Additionally, the rise in chronic diseases and the corresponding need for frequent medication administration are pushing the adoption of needle-free technologies.

The emphasis on reducing needle-stick injuries and the associated dangers has also prompted health care providers to explore this innovative delivery method further. Opportunities are emerging in the US as healthcare systems continuously seek to improve patient experience while increasing efficiency in drug delivery.

Advancements in technology have enabled the development of devices that are not only effective but also easy to use, allowing for application in both clinical and home settings. This opens up possibilities for accessing a broader patient base, including those who avoid needles due to fear or discomfort. Moreover, the growing trend towards personalized medicine is prompting the exploration of needle-free solutions for specific patient needs.

In recent times, the advancement of regulatory support and funding for needle-free technologies is making a significant impact on the market. The FDA's favorable stance towards innovative delivery systems encourages manufacturers to invest in research and development, leading to enhanced product offerings.

In parallel, increased awareness among healthcare professionals about the benefits of needle-free technology is driving its acceptance and usage across various healthcare facilities, ranging from hospitals to outpatient clinics. The combination of these factors drives a robust growth trajectory in the US Needle-Free Injection Market, presenting a compelling environment for ongoing development and adoption of these innovative solutions.

### **US Needle-Free Injection Market Drivers**

#### **Rising Demand for Vaccination Solutions**

The increasing focus on vaccination programs within the United States is driving significant growth in the US Needle-Free Injection Market Industry. According to the Centers for Disease Control and Prevention, the uptake of childhood vaccinations has seen a rise, with approximately 90% of children receiving their vaccinations before age two.

Furthermore, the COVID-19 pandemic has accelerated the need for rapid vaccination deployment, emphasizing needle-free solutions to enhance patient comfort and compliance. Organizations such as the World Health Organization have also recognized the potential of needle-free technologies in immunization programs, noting that such methods can lead to increased vaccination rates. This trend indicates a growing acceptance of needle-free injection devices, particularly in public health initiatives.

#### **Technological Advancements in Injection Devices**

Innovations in needle-free injection technology are fueling growth in the US Needle-Free Injection Market Industry. Recent advancements, such as the development of sophisticated jet injectors and spring-loaded devices, enhance the efficiency and safety of drug delivery systems. A report from the U.S. Food and Drug Administration indicates that several new needle-free injector devices have received approvals in the past few years, leading to increased market competition.

Companies like PharmaJet and Zogenix are pioneering these developments, which not only improve the user experience but also demonstrate the efficacy of needle-free technologies in delivering medications. This continuous innovation is expected to drive adoption and expand market reach.

#### **Increase in Chronic Disease Prevalence**

The growing prevalence of chronic diseases such as diabetes, cardiovascular conditions, and autoimmune diseases in the United States is a major driver for the US Needle-Free Injection Market Industry. The National Center for Chronic Disease Prevention and Health Promotion reported that six in ten adults have a chronic disease, leading to an increased need for effective and convenient drug delivery systems.

With a larger patient population requiring regular injections for disease management, the preference for needle-free devices is likely to rise. Companies like Eli Lilly and Pfizer are actively exploring needle-free solutions for administering their medications, further cementing the importance of this trend in the market.

### **US Needle-Free Injection Market Segment Insights**

#### **Needle-Free Injection Market Application Insights**

The Application segment of the US Needle-Free Injection Market presents a diverse array of opportunities influenced by evolving healthcare needs and technological advancements. As the market continues to grow, the focus on vaccinations, which is a vital component in public health initiatives, plays a crucial role in minimizing the spread of diseases and ensuring community immunity.

Insulin Delivery is another significant area of application within this market, as cases of diabetes continue to rise, necessitating innovative solutions that offer convenience and comfort to patients. The method of delivering insulin without needles addresses a major concern for many individuals who fear needles, thus promoting better adherence to their treatment regimens.

Furthermore, Pain Management is pivotal to providing relief to patients with chronic pain conditions, representing an innovative approach that reduces the discomfort associated with traditional injections. Hormonal Therapy also demonstrates its importance, particularly in managing conditions related to hormonal imbalances, which often require consistent and effective administration of medication.

This segment is becoming increasingly relevant as healthcare providers seek patient-friendly alternatives that minimize distress and improve the experience of administration. Overall, the segmentation of the US Needle-Free Injection Market reveals significant potential across various applications, each contributing to health outcomes while driving a shift towards more patient-centric and less invasive technologies.

The growing adoption of these advanced delivery systems is fueled by increasing awareness and demand for non-invasive treatment methods, positioning the US market as a leader in innovation and a significant focus for ongoing investments in Research and Development.

#### **Needle-Free Injection Market Technology Insights**

The US Needle-Free Injection Market within the Technology segment is increasingly gaining traction due to innovations aimed at improving drug delivery efficiency and patient comfort. The Jet Injector technology plays a critical role, as it delivers medication through a high-pressure jet that penetrates the skin, eliminating the need for needles and significantly reducing the risk of needlestick injuries.

Similarly, Nanoparticle Based Delivery systems are becoming prominent, as they facilitate targeted drug delivery to specific sites in the body, enhancing therapeutic effectiveness while minimizing side effects. Laser Powered Injection technology is also noteworthy, as it utilizes focused laser energy to create micro-holes in the skin for drug administration, ensuring a painless administration process.

The rise of chronic diseases and the growing emphasis on self-administration of medications among patients are driving the demand for these technologies. Along with health care provider acceptance and a growing aging population, the Needle-Free Injection Market is poised for continuous growth, contributing to improved patient compliance and safety in the delivery of therapeutic agents.

The innovations in this space reflect a shift toward more patient-centered care in the US healthcare industry.

#### **Needle-Free Injection Market End Use Insights**

The US Needle-Free Injection Market, particularly in the End Use segment, is gaining substantial traction due to its innovative approach to drug administration without traditional needles. Hospitals represent a significant demand center, primarily because they prioritize patient safety, reduce needle-stick injuries, and enhance the overall efficiency of medication delivery.

The prominence of home care is also notable, as patients increasingly prefer self-administration of therapies at home, which promotes medication adherence and comfort. Additionally, pharmaceutical companies are capitalizing on the growing trend of needle-free technologies, integrating them into their product offerings to cater to the needs of both healthcare providers and patients.

With the ongoing advancements in technology and design, the US Needle-Free Injection Market is poised for growth in these areas, responding to the evolving landscape of healthcare and patient care needs. The importance of this market segment lies in its ability to provide safer, more efficient alternatives for both patients and healthcare professionals, addressing key challenges like infection risk and administrative ease.

#### **Needle-Free Injection Market Dosage Form Insights**

The US Needle-Free Injection Market has shown significant growth potential, particularly within the Dosage Form segment, which encompasses various forms such as Solid, Liquid, and Lyophilized. The market is shaped by a trend towards more patient-friendly administration methods, reducing pain and anxiety associated with traditional injections.

Solid dosage forms have garnered attention for their stability and ease of handling, making them vital for vaccine delivery, especially during health crises. Liquid forms dominate the landscape due to their versatility in delivering a range of medications with swift absorption rates, appealing to both healthcare providers and patients.

Meanwhile, lyophilized forms, known for their long shelf-life and stability, are crucial for treatable conditions that require reconstitution before use. The segmentation within the US Needle-Free Injection Market highlights the emphasis on improving patient compliance and facilitating efficient drug delivery, which are essential for the evolving landscape of healthcare logistics.

As the healthcare industry in the US continues to prioritize innovative and patient-centric solutions, the significance of these dosage forms becomes increasingly apparent, driving advancements and investments in the Needle-Free Injection sector.

### **US Needle-Free Injection Market Key Players and Competitive Insights**

The US Needle-Free Injection Market has witnessed significant growth in recent years, driven by technological advancements and increased awareness of the benefits of needle-free systems. This market is characterized by intense competition, with various companies striving to establish their presence through innovative products and strategic partnerships. As the healthcare landscape evolves, the demand for needle-free injection systems, which offer enhanced patient comfort and safety, is also rising.

Competitive insights indicate that key players are focusing on research and development to improve product efficacy, exploring new applications in drug delivery, and expanding their market reach. Moreover, regulatory approvals and compliance with safety standards are critical factors influencing competition in this sector, compelling companies to continually adapt and innovate in order to maintain their positions and capture emerging opportunities.

Bluegrass Vascular Technologies is well-positioned within the US Needle-Free Injection Market, highlighting its strengths in product innovation and robust market presence. The company has developed unique needle-free injection technology that emphasizes safety and patient comfort, catering to a broad range of medical applications. Bluegrass Vascular Technologies has established strong relationships with medical professionals and institutions, enabling effective distribution and adoption of its technologies within the United States.

The company’s commitment to advancing needle-free delivery systems showcases its strategic approach to addressing the challenges of traditional injection methods, ultimately enhancing patient compliance and reducing the risk of needle-stick injuries. This positioning has allowed Bluegrass Vascular Technologies to carve a niche in the competitive landscape, reinforcing its resilience and potential for growth in the needle-free segment.

MediJet is another prominent player in the US Needle-Free Injection Market, known for its innovative approach to injection technology. The company specializes in developing a range of needle-free delivery systems designed for various therapeutic uses, including vaccines and biologics, which resonate well with the increasing demand for efficient drug delivery. MediJet's strengths lie in its cutting-edge technology and continuous investment in research and development, which are essential for maintaining competitiveness.

The company actively engages in strategic partnerships and collaborations to enhance its market footprint and leverage synergies in product development. Moreover, MediJet has been involved in mergers and acquisitions, further strengthening its capabilities and expanding its service offerings within the US. By focusing on quality, safety, and technological advancements, MediJet continues to position itself as a key player in the needle-free injection market, appealing to both healthcare practitioners and patients alike.

### **Key Companies in the US Needle-Free Injection Market Include**

### **US Needle-Free Injection Market Industry Developments**

The US Needle-Free Injection Market is currently experiencing notable developments, primarily driven by advancements in technology and increasing demand for pain-free injection methods. Recently, Bluegrass Vascular Technologies announced a significant increase in their market share due to the adoption of their innovative products, contributing to a more than 15% growth in market valuation within the last year.

MediJet and Injex are also gaining traction with their user-friendly designs that cater to both consumers and healthcare professionals alike. In July 2023, Bioventus expanded its portfolio by acquiring specific assets from a competitor to enhance its needle-free technology capabilities. West Pharmaceutical Services has also focused on Research and Development to advance their needle-free systems.

Additionally, the rising need for diabetes management products has propelled growth, particularly for ZyCoVD and Nemaura Medical’s offerings. The market is also influenced by regulatory shifts and increased government support for needle-free technology, marking a shift in the healthcare landscape as awareness of such solutions grows. Major happenings in the last couple of years have set the stage for further innovations and partnerships, reflecting a dynamic and evolving Needle-Free Injection Market in the US.

### **Needle-Free Injection Market Segmentation Insights**

#### **Needle-Free Injection Market Application Outlook**

#### **Needle-Free Injection Market Technology Outlook**

#### **Needle-Free Injection Market End Use Outlook**

#### **Needle-Free Injection Market Dosage Form Outlook**

## Market Drivers

### Rising Prevalence of Chronic Diseases

The increasing incidence of chronic diseases in the US is a pivotal driver for the needle free-injection market. Conditions such as diabetes, cardiovascular diseases, and respiratory disorders necessitate regular medication administration. As the population ages, the demand for efficient and less invasive drug delivery methods rises. The needle free-injection market is poised to benefit from this trend, as these devices offer a more comfortable alternative to traditional syringes. According to recent estimates, chronic diseases affect nearly 60% of adults in the US, leading to a projected growth in the market. This shift towards needle free solutions aligns with the healthcare industry's focus on improving patient compliance and reducing the burden on healthcare systems.

### Rising Awareness of Needle-Free Solutions

The growing awareness of the benefits of needle-free solutions among both healthcare professionals and patients is a key driver for the needle free-injection market. Educational campaigns and advocacy efforts are highlighting the advantages of these devices, such as reduced pain, lower risk of infection, and improved patient compliance. As awareness increases, more healthcare providers are likely to adopt needle free injectors in their practices. The needle free-injection market is expected to see a corresponding rise in demand, with market analysts suggesting a potential growth rate of 12% annually as awareness continues to spread.

### Technological Innovations in Drug Delivery

Technological advancements in drug delivery systems are significantly influencing the needle free-injection market. Innovations such as micro-jet injectors and high-velocity delivery systems enhance the efficacy and safety of medication administration. These technologies not only improve the precision of drug delivery but also minimize the risk of needle-stick injuries, which are a concern in traditional methods. The needle free-injection market is likely to see a surge in adoption as healthcare providers and patients recognize the benefits of these advanced systems. Market data indicates that the segment for needle free injectors is expected to grow at a CAGR of over 15% in the coming years, driven by these technological improvements.

### Growing Focus on Patient-Centric Healthcare

The shift towards patient-centric healthcare is a significant driver for the needle free-injection market. Healthcare providers are increasingly prioritizing patient comfort and convenience, leading to a demand for less invasive treatment options. Needle free injectors align with this trend by offering a painless and efficient method for drug delivery. This focus on patient experience is reflected in the growing adoption of these devices in outpatient settings and home healthcare. The needle free-injection market is expected to expand as more healthcare systems integrate these solutions into their practices, potentially increasing market share by 20% over the next five years.

### Increased Investment in Healthcare Infrastructure

Investment in healthcare infrastructure in the US is another critical driver for the needle free-injection market. As healthcare facilities upgrade their technologies and expand their services, the demand for innovative drug delivery systems rises. Government initiatives and private sector investments are facilitating the adoption of needle free injectors, which are seen as a means to enhance patient care and operational efficiency. The needle free-injection market stands to gain from this trend, with projections indicating that the market could reach $1 billion by 2027, fueled by these infrastructural improvements.

## Future Outlook

The [Needle Free Injection Market](https://www.marketresearchfuture.com/reports/needle-free-injection-market-6180) is projected to grow at an 8.58% CAGR from 2025 to 2035, driven by technological advancements and increasing demand for pain-free administration.

**New opportunities:**

- Development of portable needle free injectors for home use Integration of smart technology for dosage tracking Expansion into veterinary applications for efficient medication delivery

By 2035, the market is expected to achieve substantial growth, driven by innovation and diverse applications.

## Segment Insights

### By Application: Vaccination (Largest) vs. Insulin Delivery (Fastest-Growing)

In the US needle free-injection market, the application segment reveals a significant distribution of shares. Vaccination holds the largest market share due to the increasing emphasis on immunization programs and the growing acceptance of needle-free technology in vaccination practices. Conversely, insulin delivery has emerged as a notable contender, capturing a substantial share as the prevalence of diabetes continues to rise, prompting demand for efficient and pain-free delivery methods. 

The growth trends within the application segment are driven by several factors, including technological advancements and favorable regulatory support for needle-free systems. The increasing focus on patient comfort and safety has also bolstered the adoption of needle-free injections. As patient-centric solutions gain traction, insulin delivery is projected to be the fastest-growing application, while vaccination remains a stable and dominant force, reflecting its integral role in public health initiatives.

Vaccination (Dominant) vs. Insulin Delivery (Emerging)

Vaccination remains the dominant application within the US needle free-injection market, characterized by widespread use in public health initiatives and a robust framework supporting immunization efforts. Its established presence boosts market confidence, facilitating collaboration among healthcare providers and manufacturers. On the other hand, insulin delivery represents an emerging segment demonstrating rapid growth potential, fueled by the increasing incidence of diabetes and heightened consumer awareness of alternative delivery solutions. This application is becoming increasingly innovative, with ongoing developments aimed at enhancing user experiences by minimizing discomfort, thus positioning it favorably to capture a larger share of the market in the coming years.

### By Technology: Jet Injector (Largest) vs. Nanoparticle Based Delivery (Fastest-Growing)

In the US needle free-injection market, the Jet Injector segment commands a significant share, owing to its established presence and reliability in delivering vaccines and medications. This segment is preferred by healthcare providers and patients alike for its ease of use and effectiveness, solidifying its dominant position in the market. Meanwhile, the Nanoparticle Based Delivery segment is gaining traction due to its potential for targeted therapies and innovations that enhance drug absorption, which is crucial in specific medical applications.

Growth trends indicate that while Jet Injectors continue to hold a substantial market share, Nanoparticle Based Delivery is rapidly evolving, characterized by increasing investments in research and development. Key drivers for this growth include the rising demand for efficient drug delivery systems and advancements in nanotechnology. Furthermore, the laser-powered injection segment is contributing to the market by appealing to consumers seeking painless and quick delivery methods, although it currently holds a smaller market share compared to its counterparts.

Technology: Jet Injector (Dominant) vs. Nanoparticle Based Delivery (Emerging)

The Jet Injector segment is a well-established leader in the market, recognized for its capability to deliver medication without needles, thereby minimizing pain and improving patient compliance. Its applications in vaccination have made it indispensable, especially in public health initiatives. In contrast, the Nanoparticle Based Delivery technology is an emerging trend that offers innovative solutions for drug delivery, focusing on enhancing therapeutic efficacy. By utilizing nanoparticles, this technology ensures drugs are delivered more effectively to the targeted area, reducing side effects and improving overall patient outcomes. The growing focus on personalized medicine is driving this segment's expansion, as it aligns with the trend towards more tailored patient care solutions.

### By End Use: Hospitals (Largest) vs. Home Care (Fastest-Growing)

In the US needle free-injection market, the segment share is led by hospitals, which have established themselves as the most significant users of these technologies due to their extensive patient care protocols. Hospitals benefit from the efficiency and safety of needle free injections, making them a dominant force in this sector. On the other hand, home care is rapidly gaining traction, driven by increasing patient preference for at-home treatments and advancements in device technology that enhance ease of use and accessibility.

Growth trends indicate a shift towards home care as the fastest-growing segment, buoyed by an aging population and a growing demand for chronic disease management. Pharmaceutical companies are also contributing to this growth by expanding their product lines to include needle free options, enabling them to cater to the emerging home care market. The convergence of health technology innovations and a push towards patient-centric solutions is propelling this segment forward.

Hospitals (Dominant) vs. Home Care (Emerging)

The hospitals segment in the US needle free-injection market remains dominant due to their established infrastructure, high utilization rates, and strong protocols for patient management. Hospitals leverage these systems to improve patient outcomes, reduce infection rates, and minimize the use of traditional needles. Meanwhile, the home care segment is emerging rapidly as more patients seek treatment in their own environments. This shift is facilitated by advancements in needle free technology, which not only enhance patient experience but also align with the growing trend of telehealth. Both segments have distinct characteristics: hospitals prioritize efficiency and safety, whereas home care emphasizes convenience and patient autonomy, paving the way for significant sectoral growth.

### By Dosage Form: Liquid (Largest) vs. Lyophilized (Fastest-Growing)

In the dosage form segment of the US needle free-injection market, the distribution of market shares reveals significant differentiation among solid, liquid, and lyophilized forms. Liquid formulations constitute the largest portion of the market, preferred for their ease of use and versatility in administration. Solid dosage forms, while reliable, are gradually losing ground to liquids, which are fostering advancements in delivery technology. Meanwhile, lyophilized forms are gaining traction due to their benefits in stability and shelf-life, positioning them well in the competitive landscape.

Growth trends indicate a robust shift towards liquid dosage forms, driven by increasing consumer demand for non-invasive administration methods that enhance patient compliance. The emergence of sophisticated needle-free technologies is propelling the adoption of lyophilized preparations, particularly in biologics and vaccines, as they appeal to a broader audience while ensuring rapid and effective delivery. Innovations in formulation and manufacturing processes further enhance the appeal of lyophilized products, solidifying their role in the future of the US needle free-injection market.

Liquid (Dominant) vs. Lyophilized (Emerging)

Liquid dosage forms dominate the US needle free-injection market due to their widespread acceptance and practical advantages. These forms deliver medications efficiently while minimizing discomfort, making them a preferred choice among patients and healthcare providers. The flexibility of liquid formulations allows for easy integration of various drug types, resulting in a broader application range. In contrast, lyophilized forms represent an emerging segment characterized by enhanced stability and extended shelf-life, particularly in biological products. Their ability to maintain efficacy during transport and storage positions lyophilized preparations as a pivotal player in expanding the needle-free delivery system, addressing both regulatory expectations and patient safety concerns.

## Competitive Benchmarking

The needle free-injection market is currently characterized by a dynamic competitive landscape, driven by innovation and the increasing demand for painless delivery systems. Key players such as PharmaJet (US), Antares Pharma (US), and Zynerba Pharmaceuticals (US) are actively shaping the market through strategic initiatives. PharmaJet (US) focuses on enhancing its product offerings by investing in research and development, aiming to improve the efficacy and safety of its needle-free devices. Antares Pharma (US) emphasizes partnerships with pharmaceutical companies to expand its product pipeline, while Zynerba Pharmaceuticals (US) is leveraging its expertise in cannabinoid therapies to explore new applications for needle-free delivery systems. Collectively, these strategies contribute to a competitive environment that prioritizes innovation and patient-centric solutions.In terms of business tactics, companies are increasingly localizing manufacturing to reduce costs and enhance supply chain efficiency. The market appears moderately fragmented, with several players vying for market share. This fragmentation allows for diverse approaches to product development and marketing, as companies seek to differentiate themselves in a crowded marketplace. The collective influence of these key players is significant, as they drive advancements in technology and regulatory compliance, which are essential for market growth.
In October PharmaJet (US) announced a collaboration with a leading pharmaceutical company to develop a new line of needle-free injectors specifically designed for vaccine delivery. This strategic move is likely to enhance PharmaJet's market position by tapping into the growing demand for efficient vaccine administration, particularly in pediatric populations. The collaboration underscores the importance of partnerships in accelerating product development and meeting emerging healthcare needs.
In September Antares Pharma (US) launched a new needle-free injector that integrates smart technology for real-time monitoring of injection parameters. This innovation not only improves patient compliance but also provides valuable data for healthcare providers. The introduction of smart features reflects a broader trend towards digitalization in the healthcare sector, positioning Antares Pharma as a forward-thinking player in the market.
In August Zynerba Pharmaceuticals (US) secured a patent for a novel formulation that enhances the absorption of cannabinoids via needle-free delivery. This development is pivotal as it opens new avenues for therapeutic applications, potentially expanding Zynerba's market reach. The patent reinforces the company's commitment to innovation and positions it favorably against competitors.
As of November the needle free-injection market is witnessing trends such as digitalization, sustainability, and the integration of artificial intelligence in product development. Strategic alliances are increasingly shaping the competitive landscape, enabling companies to pool resources and expertise. Looking ahead, competitive differentiation is expected to evolve, with a shift from price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This transition may redefine market dynamics, emphasizing the importance of delivering superior patient experiences and outcomes.

## Recent News & Developments

The US Needle-Free Injection Market is currently experiencing notable developments, primarily driven by advancements in technology and increasing demand for pain-free injection methods. Recently, Bluegrass Vascular Technologies announced a significant increase in their market share due to the adoption of their innovative products, contributing to a more than 15% growth in market valuation within the last year.

MediJet and Injex are also gaining traction with their user-friendly designs that cater to both consumers and healthcare professionals alike. In July 2023, Bioventus expanded its portfolio by acquiring specific assets from a competitor to enhance its needle-free technology capabilities. West Pharmaceutical Services has also focused on Research and Development to advance their needle-free systems.

Additionally, the rising need for diabetes management products has propelled growth, particularly for ZyCoVD and Nemaura Medical’s offerings. The market is also influenced by regulatory shifts and increased government support for needle-free technology, marking a shift in the healthcare landscape as awareness of such solutions grows. Major happenings in the last couple of years have set the stage for further innovations and partnerships, reflecting a dynamic and evolving Needle-Free Injection Market in the US.

## Report Scope

| MARKET SIZE 2024 | 1330.11(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 1444.23(USD Million) |
| MARKET SIZE 2035 | 3289.61(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 8.58% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Zynerba Pharmaceuticals (US), MedImmune (GB), PharmaJet (US), Injex Pharma (DE), Valeritas Holdings (US), Vaxart (US), West Pharmaceutical Services (US), Antares Pharma (US) |
| Segments Covered | Application, Technology, End Use, Dosage Form |
| Key Market Opportunities | Advancements in needle free-injection technology enhance patient compliance and reduce healthcare-associated infections. |
| Key Market Dynamics | Technological advancements drive growth in the needle free-injection market, enhancing patient compliance and reducing needle-related injuries. |
| Countries Covered | US |

## Frequently Asked Questions

**Q: What was the market valuation of the US needle free-injection market in 2024?**
A: The market valuation was $1330.11 Million in 2024.

**Q: What is the projected market valuation for the US needle free-injection market by 2035?**
A: The projected valuation for 2035 is $3289.61 Million.

**Q: What is the expected CAGR for the US needle free-injection market during the forecast period 2025 - 2035?**
A: The expected CAGR during this period is 8.58%.

**Q: Which application segment had the highest valuation in the US needle free-injection market in 2024?**
A: The Vaccination and Insulin Delivery segments each had a valuation of $399.03 Million in 2024.

**Q: What is the projected valuation for the Pain Management application segment by 2035?**
A: The projected valuation for the Pain Management segment is $640.0 Million by 2035.

**Q: Which technology segment is expected to show the highest growth in the US needle free-injection market?**
A: The Nanoparticle Based Delivery segment is projected to grow from $500.0 Million to $1200.0 Million by 2035.

**Q: What was the valuation of the Home Care end-use segment in 2024?**
A: The Home Care end-use segment had a valuation of $300.0 Million in 2024.

**Q: Which dosage form segment is expected to have the highest valuation by 2035?**
A: The Liquid dosage form segment is projected to reach $2000.0 Million by 2035.

**Q: Who are the key players in the US needle free-injection market?**
A: Key players include Zynerba Pharmaceuticals, PharmaJet, and Antares Pharma, among others.

**Q: What is the expected trend for the US needle free-injection market in the coming years?**
A: The market is likely to experience robust growth, driven by advancements in technology and increasing demand for needle-free solutions.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-needle-free-injection-market-53306*